Clinical trial for mesothelioma antitumor drug underway
Written by Jason Wentworth Monday, 19 April 2010 16:46The asbestos cancer mesothelioma is primarily an occupational disease. People who have worked with asbestos-containing products such as gaskets, brake pads and roofing shingles are at risk of developing mesothelioma cancer. Mesothelioma cancer has a long latency period i.e., the disease can show decades after exposure to asbestos.
The asbestos cancer mesothelioma currently has no cure but there are care options that can improve the quality of life for people suffering from mesothelioma cancer. In addition, there are several clinical trials for experimental drugs for the treatment of mesothelioma. People diagnosed with mesothelioma may benefit from participating in clinical trials for mesothelioma cancer drugs.
Presently, the Italian biotechnology company MolMed S.p.A. is conducting a Phase III clinical trial on the antitumor drug NGR-hTNF. People who have been diagnosed with malignant pleural mesothelioma may be eligible to participate in the study. The study is seeking 400 patients in whom there was a progression of mesothelioma after premetrexed based chemotherapy. During the course of the study, patients will receive NGR-hTNF and upon recommendation, doxorubicin, gemcitabine or vinorelbine. The goal of the clinical trial is to improve survival rate but the study will also monitor mesothelioma control rate and quality of life. The results of earlier clinical trials for the drug have been encouraging.
For more information about the clinical trials, please contact Kumar Singh at email@example.com .
This press release was prepared by the law firm of Weitz & Luxenberg. Weitz & Luxenberg is a New York law firm that specializes in helping people with mesothelioma obtain financial assistance through mesothelioma lawsuits. If you or a loved one has been diagnosed with the asbestos cancer mesothelioma, contact a Weitz & Luxenberg mesothelioma lawyer for a free case review by visiting www.weitzlux.com. For information on jobs that involve the risk of asbestos exposure and mesothelioma, visit www.mesotheliomajobs.com.